Biotech · Private company
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
Track this companyFree. Adds Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) to your Dealase workspace and tells you when its record changes.
Clinical trials63 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- 18F-MFBGPhase 3 · NeuroblastomaClinicalTrials.gov · fetched Nov 12, 2026
- 18F-metaFluorobenzylguanidinePhase 2 · Heart FailureClinicalTrials.gov · fetched Nov 12, 2026
- 18F-MFBGPhase 2 · Parkinson Disease (PD)ClinicalTrials.gov · fetched Nov 12, 2026
- 18F-mFBG for intravenous administrationPhase 2 · Cardiovascular DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- Rubidium-82Phase 2 · Heart FailureClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Prospective Image Reevaluation Study to Assess the Efficacy of 18F-mFBG PET Imaging in Subjects With NeuroblastomaCOMPLETED · started Jun 1, 2026ClinicalTrials.gov NCT07833631 · fetched Nov 12, 2026
- 18F-mFBG Cardiac Uptake With Lewy Body DementiaPHASE2 · RECRUITING · started Apr 30, 2026ClinicalTrials.gov NCT07176286 · fetched Nov 12, 2026
- 18F-mFBG Imaging for Myocardial Sympathetic InnervationPHASE2 · RECRUITING · started Nov 5, 2025ClinicalTrials.gov NCT06965621 · fetched Nov 12, 2026
- 18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous SystemPHASE2 · WITHDRAWN · started Jan 1, 2025ClinicalTrials.gov NCT06233903 · fetched Nov 12, 2026
- Open-Label Study of 18F-mFBG for Imaging NeuroblastomaPHASE3 · COMPLETED · started Nov 18, 2021ClinicalTrials.gov NCT04724369 · fetched Nov 12, 2026
- Open-Label Study of 18F-mFBG for Imaging Myocardial Sympathetic InnervationPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Nov 5, 2021ClinicalTrials.gov NCT04535193 · fetched Nov 12, 2026